Merck

  • Zontivity 2015 report

    Zontivity 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Zostavax 2015 report

    Zostavax 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this Report:...

  • Asmanex 2014 report

    Asmanex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Dulera 2014 report

    Dulera 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Emend 2014 report

    Emend 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 23 Pages The 5 Key Questions Addressed by this...

  • Follistim 2014 report

    Follistim 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Ganirelix 2014 report

    Ganirelix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Gardasil 2014 report

    Gardasil 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 20 Pages The 5 Key Questions Addressed by this Report:...

  • Grastek 2014 report

    Grastek 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Integrilin 2014 report

    Integrilin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Intron A 2014 report

    Intron A 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 21 Pages The 5 Key Questions Addressed by...

  • Invanz 2014 report

    Invanz 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...